Post-IPO Debt Funded Startups in United States
Among the 50 most recent post-IPO debt rounds shown, the largest disclosed amount is Thermo Fisher Scientific’s $741M (2022-10-14), and it sits well above…
Among the 50 most recent post-IPO debt rounds shown, the largest disclosed amount is Thermo Fisher Scientific’s $741M (2022-10-14), and it sits well above the broader pack where many rounds cluster between $25M and $425M. The distribution is notably top-heavy: Carnival Corporation raised $2.0B on 2022-10-18 and Medtronic raised $3.5B on 2022-09-15, both dwarfing the next-largest values.
Date concentration is visible in mid-October 2022, with multiple entries on 2022-10-18 (Carnival $2.0B; HS GovTech $2M; Sezzle $100M) and 2022-10-19 (Insmed $500M; Tricida $125M). Sector-wise, biotechnology is a recurring theme (e.g., Insmed 2022-10-19 $500M; Alnylam Pharmaceuticals 2022-09-13 $900M; Medtronic 2022-09-15 $3.5B), while the smallest disclosed round is HS GovTech’s $2M (2022-10-18). Geographically, California-based companies recur (e.g., Milpitas for View on 2022-10-27; Menlo Park for Tricida on 2022-10-19 and Oportun on 2022-09-15), with single-city entries also appearing in New York (Acreage Holdings $25M on 2022-10-25; Kimco Realty $650M on 2022-08-10).
Most recent rounds
50 shownRelated listings
Frequently asked
What’s the biggest disclosed post-IPO debt round in this list, and is it an outlier versus the rest?
Carnival Corporation’s $2.0B (2022-10-18) is the clear outlier in disclosed size, exceeding the next-largest amounts like Medtronic’s $3.5B (2022-09-15) and Thermo Fisher Scientific’s $741M (2022-10-14) while dwarfing most rounds in the $25M–$425M band (e.g., UGE $5M on 2022-10-25; Insmed $500M on 2022-10-19).
Do the most recent rounds cluster around a specific time window?
Yes. Several rounds land in a tight mid-to-late October 2022 window, including 2022-10-18 (Carnival $2.0B; HS GovTech $2M; Sezzle $100M) and 2022-10-19 (Insmed $500M; Tricida $125M), with the newest entry dated 2022-10-27 (View at $200M).
Are any sectors over-represented among these post-IPO debt rounds?
Biotechnology appears repeatedly, including Insmed ($500M, 2022-10-19), Thermo Fisher Scientific ($741M, 2022-10-14), Alnylam Pharmaceuticals ($900M, 2022-09-13), and Medtronic ($3.5B, 2022-09-15). Other sectors show fewer repeated entries—for example, “Energy” appears at Sunnova ($425M, 2022-08-15), BWX Technologies ($250M, 2022-10-14), and UGE ($5M, 2022-10-25).
Which cities/states appear more than once, suggesting a geographic concentration?
California-based companies recur across the window, including Milpitas (View, 2022-10-27, $200M), Menlo Park (Tricida, 2022-10-19, $125M and Oportun, 2022-09-15, $150M), and Pasadena (Rockley Photonics, 2022-10-03, $10M). New York also repeats, with Acreage Holdings ($25M, 2022-10-25) and Kimco Realty ($650M, 2022-08-10) both appearing on different dates.
What are the extremes: smallest disclosed amount and its context?
The smallest disclosed amount is HS GovTech’s $2M (2022-10-18). That tiny figure sits alongside much larger disclosed rounds on the same date, such as Carnival’s $2.0B (2022-10-18) and Sezzle’s $100M (2022-10-18), indicating a wide spread even within a single day’s set.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.